Check out your Company Bowl for anonymous work chats.
http://glassdoor.com/slink.htm?key=vQ48x interviewed Dr. Gunjan Bhardwaj on how DaaS (Data as a Service) is the only way going forward to provide intelligence to Indian healthcare enterprises. Read the full article here: http://glassdoor.com/slink.htm?key=vQ48q India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines
iPlexusᵀᴹ is THE Intelligence Machineᵀᴹ that is transforming decision support in the Life Sciences industry! An insight discovery platform to help you make the right decisions. All the research data you need is crawled, extracted and analyzed for your decision support - using full automation! We have Terabytes of data from trials, research, congresses, publications and much more. Don’t miss trying it for FREE. We’re giving out beta invites. Get yours now! http://glassdoor.com/slink.htm?key=vQ48r
According to WHO, amongst the three highest disability classes, 8 out of 10 are Neurological disorders! Want to know more? Check out our infographic on Neurological disorders here: http://glassdoor.com/slink.htm?key=vQ48k
Our colleague from the AI team, Tanay Gahlot has published an awesome article on Medium. You can read it here: http://glassdoor.com/slink.htm?key=vQ48M
Check out our latest infographic on 3 Interesting Facts about Drug Development - http://glassdoor.com/slink.htm?key=vQ48Q
Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexusᵀᴹ platform to RCC, Gwalior. The academic license allows doctors and researchers with free access to iPlexusᵀᴹ, an end-to-end platform for Life Sciences. Doctors and researchers will be able to gain insights into the latest advancements in research and trials related to cancer.
Innoplexus in News - http://glassdoor.com/slink.htm?key=vQ48I
Innoplexus is happy to announce the closing of Pre Series A funding from HCS, a Germany based Venture Capital Fund. Hans-Christian Semmler, managing shareholder of HCS, will join as Chairman of the supervisory board of Innoplexus. With the capital raised, Innoplexus plans to file more patent applications, further develop the platform and invest in marketing.
Modern Data Analysis in the Pharmaceutical Industry - Dr. Gunjan Bhardwaj, CEO Innoplexus Read full article: http://glassdoor.com/slink.htm?key=vQ481
